Fundraising FoxObalon Therapeutics, Inc.
acquired by RESHAPE LIFESCIENCES INCCarlsbad, US · Founded 2008 · Delaware corporation · 1 known investors
Find your way into Obalon Therapeutics, Inc.
Sign up to see every warm intro you have to Obalon Therapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Obalon Therapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by ReShape Lifesciences Inc. June 2021 · $30.6M ($30.6 million in stock (3,340,035 shares)) · source ↗
Obalon Therapeutics was a Carlsbad, California medical device company that developed an FDA-approved swallowable, gas-filled intragastric balloon system for non-surgical weight loss in obese adults.
Founders & leadership
KH
Kelly Huang, Ph.D.Chief Operating Officer
WJ
William J. PlovanicChief Financial Officer
AR
Andrew RasdalPresident and Chief Executive Officer
LH
Les HoweNamed on SEC filing
DF
Douglas FisherNamed on SEC filing
DM
David MoatazediNamed on SEC filing
SS
Sharon Stevenson, DVM Ph.D.Named on SEC filing
Board
KK
Kim Kamdar, Ph.D.Board director
KP
Kim Puloma KamdarBoard director
SS
Sharon StevensonBoard directorCo-Founder, Managing Director, Venture Partner at Okapi Venture Capital
RD
Raymond DittamoreBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$27.4M disclosed across 3 rounds · 2012–2018
▶$10MraisedAug 2018 · 21 investors · BiotechnologyRule 506(b)
▶$10MraisedAug 2018 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Les HoweDirector
- Mark BristerExecutive Officer
- Kelly Huang, Ph.D.Executive Officer
- Douglas FisherDirector
- David MoatazediDirector
- Raymond DittamoreDirector
- Sharon Stevenson, DVM Ph.D.Director
- Kim Kamdar, Ph.D.Director
- William J. PlovanicExecutive Officer
- Andrew RasdalExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.9MraisedOct 2014 · 5 investors · BiotechnologyRule 506(b)
▶$15.9MraisedOct 2014 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Doug FisherDirector
- Kim Puloma KamdarDirector
- Andrew RasdalExecutive Officer, Director
- Sharon StevensonDirector
- Offering amount
- $30M
- Amount sold
- $15.9M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMar 2012 · 2 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMar 2012 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew RasdalExecutive Officer, Director
- Douglas C. SampsonDirector
- Kim Puloma KamdarDirector
- Sharon StevensonDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2008
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Obalon Therapeutics, Inc. do?
- Obalon Therapeutics was a Carlsbad, California medical device company that developed an FDA-approved swallowable, gas-filled intragastric balloon system for non-surgical weight loss in obese adults.
- Who are Obalon Therapeutics, Inc.'s investors?
- Obalon Therapeutics, Inc.'s investors include Okapi Venture Capital.
- How much funding has Obalon Therapeutics, Inc. raised?
- Obalon Therapeutics, Inc. has disclosed $27.4M raised across 3 rounds.
- Who acquired Obalon Therapeutics, Inc.?
- Obalon Therapeutics, Inc. was acquired by RESHAPE LIFESCIENCES INC.
- Where is Obalon Therapeutics, Inc. headquartered?
- Obalon Therapeutics, Inc. is headquartered in Carlsbad, US.